| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $376.9M | $617.6M | $716.3M |
| YoY Revenue Growth % | -39.0% | -13.8% | — |
| Gross Profit | $224.8M | $436.6M | — |
| Gross Margin % | 59.6% | 70.7% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$116.9M | -$737.1M | -$67.7M |
| Operating Margin % | -31.0% | -80.0% | -9.5% |
| Net Income (GAAP) | -$103.0M | -$837.0M | $18.0M |
| EBITDA (Normalized) | -$94.4M | -$677.1M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $15.5M | $125.2M | $246.2M |
| Capital Expenditures (CapEx) | $28.1M | $75.0M | — |
| Free Cash Flow (FCF) | -$12.6M | $50.3M | $246.2M |
| FCF Margin % | -3.4% | 8.1% | 34.4% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | $31.1M | $161.5M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $119.6M | $193.0M | — |